Pathlab Singapore has been providing its services to the medical fraternity and the general public since 1952.
Multi-Cancer Early Detection (MCED)
What is MCED?
Multi-Cancer Early Detection Test (MCED) is a simple blood test that can detect up to 113 types of cancer. Unlike the traditional cancer tests, our MCED test analyzes circulating biomarkers in the blood to detect subtle signals associated with over 50+ common cancers. This includes hard-to-screen cancers with no routine tests available, giving you and your healthcare provider unprecedented insight into your cancer risk long before it becomes symptomatic.
In partnership with AGTC Genomics, all tests are conducted in AGTC Genomics lab which is a
CAP accredited lab and also certified by other Accreditations including ISO 17025 and ISO 15189. The test has been awarded the MySTI certificate by MOSTI Malaysia.
.png)
Comprehensive
Our Comprehensive Package covers 113 Cancer Tests over 20 Categories and provides the best insight into any cancer.
.png)
Women
The Women's Package covers 55 tests over 14 categories and is suitable for woman to look into targeted catagories of cancer.
Men
The Men's Package covers 32 tests over 11 categories which covers majority of the cancers.
Basic Women
The Basic Women's Package covers 24 tests over 5 categories that looks into the most common type of cancers for women.
Basic Men
The Basic Men's Package covers 16 tests over 5 categories which looks into the most common type of cancer for men.
For more information on the MCED Test,
please contact our Business Development Team at: